These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10228296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.
    Mueller BU, Nelson RP, Sleasman J, Zuckerman J, Heath-Chiozzi M, Steinberg SM, Balis FM, Brouwers P, Hsu A, Saulis R, Sei S, Wood LV, Zeichner S, Katz TT, Higham C, Aker D, Edgerly M, Jarosinski P, Serchuck L, Whitcup SM, Pizzuti D, Pizzo PA.
    Pediatrics; 1998 Mar; 101(3 Pt 1):335-43. PubMed ID: 9480994
    [Abstract] [Full Text] [Related]

  • 3. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
    Carr A, Emery S, Kelleher A, Law M, Cooper DA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec 01; 13(4):320-6. PubMed ID: 8948369
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 6. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M.
    AIDS; 1998 Nov 12; 12(16):2115-23. PubMed ID: 9833852
    [Abstract] [Full Text] [Related]

  • 7. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
    Kelleher AD, Carr A, Zaunders J, Cooper DA.
    J Infect Dis; 1996 Feb 12; 173(2):321-9. PubMed ID: 8568292
    [Abstract] [Full Text] [Related]

  • 8. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
    Vigano A, Vella S, Saresella M, Vanzulli A, Bricalli D, Di Fabio S, Ferrante P, Andreotti M, Pirillo M, Dally LG, Clerici M, Principi N.
    AIDS; 2000 Feb 18; 14(3):251-61. PubMed ID: 10716501
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.
    J Infect Dis; 2001 Apr 01; 183(7):1116-20. PubMed ID: 11237839
    [Abstract] [Full Text] [Related]

  • 11. A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir.
    Pelton SI, Johnson D, Chadwick E, Baldwin Z, Yogev R.
    Pediatr Infect Dis J; 1999 Jul 01; 18(7):650-2. PubMed ID: 10440447
    [No Abstract] [Full Text] [Related]

  • 12. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debré P, Leibowitch J.
    Science; 1997 Jul 04; 277(5322):112-6. PubMed ID: 9204894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection.
    De Luca M, Miccinesi G, Chiappini E, Zappa M, Galli L, De Martino M.
    Int J Immunopathol Pharmacol; 2005 Jul 04; 18(4):729-35. PubMed ID: 16388722
    [Abstract] [Full Text] [Related]

  • 17. Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment.
    Ullum H, Katzenstein T, Aladdin H, Nielsen C, Sondergaard SR, Gerstoft J, Skinhoj P, Pedersen BK.
    Scand J Immunol; 1999 May 04; 49(5):539-47. PubMed ID: 10320648
    [Abstract] [Full Text] [Related]

  • 18. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
    Levacher M, Bouscarat F, Landman R, Chau F, Damond F, Gaudebout C, Mathez D, Leibowitch J, Saimot AG, Sinet M.
    AIDS Res Hum Retroviruses; 2000 Nov 20; 16(17):1869-75. PubMed ID: 11118072
    [Abstract] [Full Text] [Related]

  • 19. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection.
    Bisset LR, Cone RW, Fischer M, Battegay M, Vernazza PL, Dubs RW, Weber R, Grob PJ, Opravil M, Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr; 2001 Jul 01; 27(3):266-71. PubMed ID: 11464146
    [Abstract] [Full Text] [Related]

  • 20. Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy.
    Tran TA, Ghosn J, Avettand-Fenoël V, Hendel-Chavez H, de Goër de Herve MG, Cohen-Codar I, Rouzioux C, Delfraissy JF, Taoufik Y.
    J Antimicrob Chemother; 2015 Sep 01; 70(9):2627-31. PubMed ID: 26023212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.